BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 1933859)

  • 1. Importance of transforming growth factor alpha/epidermal growth factor receptor autocrine growth mechanism in an ovarian cancer cell line in vivo.
    Kurachi H; Morishige K; Amemiya K; Adachi H; Hirota K; Miyake A; Tanizawa O
    Cancer Res; 1991 Nov; 51(21):5956-9. PubMed ID: 1933859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of transforming growth factor alpha/epidermal growth factor receptor autocrine growth mechanism in an ovarian cancer cell line in vitro.
    Morishige K; Kurachi H; Amemiya K; Adachi H; Inoue M; Miyake A; Tanizawa O; Sakoyama Y
    Cancer Res; 1991 Nov; 51(21):5951-5. PubMed ID: 1718591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of epidermal growth factor receptor function by bivalent and monovalent fragments of 225 anti-epidermal growth factor receptor monoclonal antibodies.
    Fan Z; Masui H; Altas I; Mendelsohn J
    Cancer Res; 1993 Sep; 53(18):4322-8. PubMed ID: 8364927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for the involvement of transforming growth factor alpha and epidermal growth factor receptor autocrine growth mechanism in primary human ovarian cancers in vitro.
    Morishige K; Kurachi H; Amemiya K; Fujita Y; Yamamoto T; Miyake A; Tanizawa O
    Cancer Res; 1991 Oct; 51(19):5322-8. PubMed ID: 1717146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor-alpha acts as an autocrine growth factor in ovarian carcinoma cell lines.
    Stromberg K; Collins TJ; Gordon AW; Jackson CL; Johnson GR
    Cancer Res; 1992 Jan; 52(2):341-7. PubMed ID: 1309440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autocrine transforming growth factor alpha is dispensible for v-rasHa-induced epidermal neoplasia: potential involvement of alternate epidermal growth factor receptor ligands.
    Dlugosz AA; Cheng C; Williams EK; Darwiche N; Dempsey PJ; Mann B; Dunn AR; Coffey RJ; Yuspa SH
    Cancer Res; 1995 May; 55(9):1883-93. PubMed ID: 7728756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiangiogenic and antitumor activity of anti-epidermal growth factor receptor C225 monoclonal antibody in combination with vascular endothelial growth factor antisense oligonucleotide in human GEO colon cancer cells.
    Ciardiello F; Bianco R; Damiano V; Fontanini G; Caputo R; Pomatico G; De Placido S; Bianco AR; Mendelsohn J; Tortora G
    Clin Cancer Res; 2000 Sep; 6(9):3739-47. PubMed ID: 10999768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of transforming growth factor-alpha and its receptor in the growth response of cultured human epidermal cells to retinoic acid.
    Piazza GA; Ritter JL
    Epithelial Cell Biol; 1993 Oct; 2(4):170-5. PubMed ID: 8269032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effect of anti-epidermal growth factor receptor antibody on a human gastric cancer.
    Teramoto T; Onda M; Tokunaga A; Asano G
    Cancer; 1996 Apr; 77(8 Suppl):1639-45. PubMed ID: 8608556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidermal growth factor receptors in human breast carcinoma cells: a potential selective target for transforming growth factor alpha-Pseudomonas exotoxin 40 fusion protein.
    Arteaga CL; Hurd SD; Dugger TC; Winnier AR; Robertson JB
    Cancer Res; 1994 Sep; 54(17):4703-9. PubMed ID: 8062268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal growth factor receptor-mediated autocrine and paracrine stimulation of human transitional cell carcinoma.
    Gleave ME; Hsieh JT; Wu HC; Hong SJ; Zhau HE; Guthrie PD; Chung LW
    Cancer Res; 1993 Nov; 53(21):5300-7. PubMed ID: 8221665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor-alpha promotes tumor markers secretion from human ovarian cancers in vitro.
    Kurachi H; Adachi H; Morishige K; Adachi K; Takeda T; Homma H; Yamamoto T; Miyake A
    Cancer; 1996 Sep; 78(5):1049-54. PubMed ID: 8780543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abrogation of transforming growth factor-alpha/epidermal growth factor receptor autocrine signaling by an RXR-selective retinoid (LGD1069, Targretin) in head and neck cancer cell lines.
    Song JI; Lango MN; Hwang JD; Drenning SD; Zeng Q; Lamph WW; Grandis JR
    Cancer Res; 2001 Aug; 61(15):5919-25. PubMed ID: 11479234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of tyrosine kinase activity on malign transformation of ovarian tumors: a comparison between EGF-R and TGF-alpha.
    Zeren T; Inan S; Seda Vatansever H; Ekerbicer N; Sayhan S
    Acta Histochem; 2008; 110(3):256-63. PubMed ID: 18054376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumorigenic transformation of NIH 3T3 cells by the autocrine synthesis of transforming growth factor alpha.
    Ju WD; Velu TJ; Vass WC; Papageorge AG; Lowy DR
    New Biol; 1991 Apr; 3(4):380-8. PubMed ID: 2065023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential dependence of the tumorigenicity of chemically transformed rat liver epithelial cells on autocrine production of transforming growth factor alpha.
    Duddy SK; Earp HS; Russell WE; Smith GJ; Grisham JW
    Cell Growth Differ; 1995 Mar; 6(3):251-61. PubMed ID: 7794793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of autocrine gastrin expression by the TGF alpha autocrine loop.
    Howell GM; Ziober BL; Humphrey LE; Willson JK; Sun L; Lynch M; Brattain MG
    J Cell Physiol; 1995 Feb; 162(2):256-65. PubMed ID: 7822434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of human transforming growth factor alpha by Chinese hamster ovarian tumors in nude mice causes hypercalcemia and increased osteoclastic bone resorption.
    Yates AJ; Boyce BF; Favarato G; Aufdemorte TB; Marcelli C; Kester MB; Walker R; Langton BC; Bonewald LF; Mundy GR
    J Bone Miner Res; 1992 Jul; 7(7):847-53. PubMed ID: 1642153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibody 425 inhibits growth stimulation of carcinoma cells by exogenous EGF and tumor-derived EGF/TGF-alpha.
    Rodeck U; Williams N; Murthy U; Herlyn M
    J Cell Biochem; 1990 Oct; 44(2):69-79. PubMed ID: 2250044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor activity of anti-epidermal growth factor receptor monoclonal antibodies and cisplatin in ten human head and neck squamous cell carcinoma lines.
    Hoffmann T; Hafner D; Ballo H; Haas I; Bier H
    Anticancer Res; 1997; 17(6D):4419-25. PubMed ID: 9494544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.